ABSTRACT
less invasive therapies for management of conditions previously treated by hysterectomy 1 , they remain the most common major gynecological operation, with more than 600 000 procedures performed in the United States annually, of which 40% are laparoscopic hysterectomies (LH) 2, 3 . Australia saw an increasing trend towards vaginal hysterectomy and LH over the period from 1981 to 2000, with the number of abdominal hysterectomies declining consistently, from over 75% of all hysterectomies to approximately 53% 4 . More recently, LH has continued to gain preference amongst gynecologists 5 , with progression towards laparoscopic subtotal and total hysterectomies for specimens that are too large for vaginal hysterectomy. To enable removal of adenomyotic or fibroid uteri via laparoscopic incisions, morcellation, particularly power morcellation, has been employed to reduce the size of the tissue. Recently, however, the United States Food and Drug Administration (FDA) released a warning against the use of power morcellation of uterine leiomyomas given the potential for dissemination of malignant tissue 6 from uterine leiomyosarcomas (LMS). This has caused some concern amongst gynecologists, given the low incidence of uterine LMS compared with the benefits of minimally invasive surgery 3 . There are limited data, if any, on preoperative diagnostic tools to predict the need to morcellate. If such a tool were readily available, the laparoscopic surgeon could decide in advance whether the risks associated with morcellation (i.e. dissemination of cells from an undiagnosed LMS) outweigh the benefits (i.e. avoiding open hysterectomy) on an individual basis: if a need for morcellation could be predicted with a good degree of certainty, for example in women with an enlarged fibroid uterus, the laparoscopic surgeon could arrange second-tier investigations, such as magnetic resonance imaging 7, 8 and/or uterine curettage 8, 9 , to further improve the detection of underlying LMS and in so doing prevent the use of power morcellation in these cases. However, none of these methods can detect or rule out LMS definitively to predict the safety of morcellation.
The aim of this study was to evaluate the use of preoperative uterine volume, estimated using three-dimensional (3D) transvaginal ultrasound (US) 10 , to predict the need for morcellation in women undergoing LH, or conversely to avoid missing the need for morcellation.
METHODS

Data collection
This was a prospective observational study performed between October 2008 and November 2011 in women scheduled to undergo LH at a tertiary referral gynecological US and advanced laparoscopic unit at Nepean Hospital, Sydney, Australia. This data collection predates the FDA and American Association of Gynecologic Laparoscopists warning in relation to the use of morcellation in uterine leiomyomas 6, 8 . Data from these women have been analyzed to estimate uterine volume using two-dimensional (2D) and 3D-US measurements, and these results published elsewhere 10 . Approval was obtained from the local Human Research Ethics Committee of Nepean Blue Mountains Local Health District (HREC 08/044) and informed consent was obtained from all women.
All women scheduled for LH underwent a standardized analysis of history and detailed transvaginal US examination. During this visit, the attending physician collected baseline clinical data including age, sociodemographics, symptoms, parity and previous obstetric and gynecological history. All preoperative US examinations were performed by experienced clinicians who had performed at least 1000 scans previously.
Ultrasound examination
Detailed preoperative US was performed using an Accuvix V20 Prestige or a Medison X8 (Samsung Medison, Seoul, South Korea) ultrasound machine equipped with a 4-9-MHz transvaginal transducer. 2D images of the uterus, including the cervix, were obtained in both midsagittal and transverse planes. 2D-US measurements of the uterus (anteroposterior, longitudinal and transverse diameters) were recorded in mm and uterine volume estimated using the ellipsoid formula: anteroposterior diameter × longitudinal diameter × transverse diameter × 0.5236.
3D volumetric acquisitions were also obtained for each uterus, including the cervix, in the mid-sagittal plane. The 3D uterine volumetric datasets were reviewed offline using SonoView Pro™ (SONOTEC Ultraschallsensorik Halle GmbH, Halle (Saale), Germany) and uterine volumes were estimated using Virtual Organ Computer-aided AnaLysis™ (VOCAL™). To achieve this, the outline of the uterus was traced manually using 3D-US with six rotational steps, 30
• apart. After manual outlining of the uterus in six planes, the 3D-US program automatically displayed the 3D reconstructed uterus with its estimated volume. All offline analyses of 3D volumes were carried out by the same operator (G.C.) with experience in this technique. The uterine shape and contour is better mapped out when using 3D-US rather than 2D-US alone.
Surgical technique
All LH procedures were performed by a single operator (G.C.) using laparosonic coagulating shears (Ethicon Endosurgery, Cincinnati, OH, USA) and bipolar diathermy forceps (B-Braun, Aesculap, Tuttlingen, Germany). Once the uterus was devascularized and after opening the vaginal vault, an attempt to remove the uterus was made via the vaginal route. This was done by gently applying traction on the uterine cervix using two vulsellum forceps. Women whose uterus could be extracted vaginally were included in the final non-morcellation group. Those in whom vaginal extraction of the uterus was not possible underwent reduction of uterine volume, performed laparoscopically by corporal power morcellation of the uterus, and were included in the morcellation group. The need to morcellate at the time of LH and the final uterine dry weight (UDW) at histology were recorded.
Statistical analysis
3D-US has been found to be significantly more accurate in the estimation of uterine volume and to correlate better with UDW than 2D-US 10 . To verify this in our population, we further analyzed the correlation of our 3D-US and 2D-US uterine volumes with UDW using regression analysis.
To evaluate the use of 3D-US to predict the need to morcellate in women scheduled to undergo LH, we incorporated the estimated uterine volumes manually into our previously published logistic regression model 11 . In that study, the independent prognostic variables included in the model to predict the need to morcellate at the time of LH were parity and UDW:
where weight is UDW in g.
For both nulliparous and parous women, for any given UDW, the logistic regression model predicted the need to morcellate as a percentage (Figure 1 ). Based on the fact that the correlation coefficient, R, between actual UDW and 3D-US (VOCAL™) uterine volume was 0.97 10 , we replaced UDW in the previously published formula 11 with 3D-US volume as follows:
where 3D-US volume is volume of uterus in mL, estimated using 3D-US.
To compare the performance of 3D-US vs 2D-US uterine volumes, we repeated the above analysis by replacing UDW in the previously published formula 
where 2D-US volume is volume of uterus in mL, estimated using 2D-US.
Receiver-operating characteristics (ROC) curve analysis was used to evaluate the performance of the logistic regression model in predicting the need to morcellate. An area under the ROC curve (AUC) > 0.75 was considered suitable for clinical application 12 .
We then used different arbitrary probability threshold cut-offs at and above which we calculated the performance of the morcellation prediction model. The predicted probability for morcellation threshold cut-offs were set at 0.5, 0.7 and 0.9. The uterine volumes and parity of each woman were incorporated into the logistic regression model to predict the need to morcellate and compared with the gold standard of actual need to morcellate at the time of LH. The UDW was also entered manually into the morcellation prediction model to confirm the previously reported correlation 10 . In essence, when the predicted probability of morcellation was set at ≥ 0.5, if the predicted probability of morcellation was ≥ 50% and the woman did have morcellation at the time of LH, she was classified as a true positive; if the predicted probability of morcellation was ≥ 50% and the woman did not have morcellation at the time of LH, she was classified as a false positive; if the predicted probability of morcellation was < 50% and the woman did not have morcellation at the time of LH, she was classified as a true negative; if the predicted probability of morcellation was < 50% and the woman did have morcellation at the time of LH, she was classified as a false negative.
The performance of the logistic regression model for each predicted probability of need to morcellate was evaluated for uterine volumes calculated using both 3D-US and 2D-US, in terms of sensitivity, specificity, positive and negative predictive values, positive likelihood ratio (LR+) and negative likelihood ratio (LR-). Following the results of the ROC curve analysis, we further analyzed the performance of the predicted probability of morcellation cut-off with a sensitivity of 95%.
RESULTS
LH was performed in 76 women during the study period. Complete data, including 3D-US volumes, parity, UDW and the need to morcellate at the time of LH, were available in 79% (60/76) of cases and 2D-US volumes were available in 50 of these 60 (91.7%) cases. The mean age of the 60 women was 43.7 years, 91.7% were parous and a total of 35% underwent morcellation, of whom 85% had fibroid uteri and 15% had adenomyosis alone. The mean UDW was 295 (median, 189; range, 24-1429) g. The greatest uterine volume that did not require morcellation was 404 mL using 3D-US, which corresponded to a uterine volume of 688.8 mL using 2D-US. Conversely, the smallest uterine volume that required morcellation was 118.9 mL using 3D-US, which corresponded to a uterine volume of 123.4 mL using 2D-US. Uterine volumes obtained using 3D-US outperformed those obtained by 2D-US with regards to their correlation to UDW (R = 0.97, P < 0.001 compared with R = 0.71, P < 0.001). There were no reported sarcomas on histopathology. The AUCs for the morcellation logistic regression model were 0.769 (95% CI, 0.653-0.886) and 0.586 (95% CI, 0.419-0.753) using volumes obtained by 3D-US and 2D-US, respectively (Figure 2a,b) . The AUCs using 3D-US and 2D-US alone were determined as 0.938 (95% CI, 0.879-0.996) and 0.815 (95% CI, 0.681-0.948), respectively (Figure 2c,d) .
The uterine volume for parous women with a sensitivity of 95% based on ROC-curve analysis was 118.8 mL using 
Table 1
Performance of predicted probability of need to morcellate for three-dimensional (3D) (n = 60) and two-dimensional (2D) (n = 50) ultrasound (US) uterine volumes Performance of predicted probability of: 0.14 0.5 0.7 0.9 Nulliparous = 20 mL Nulliparous = 120 mL Nulliparous = 160 mL Nulliparous = 240 mL Parous = 120 mL Parous = 220 mL Parous = 280 mL Parous = 350 mL
3D-US 2D-US 3D-US 2D-US 3D-US 2D-US 3D-US 2D-US
True positive (n) 3D-US, which, when rounded up to 120 mL, equated to a predicted probability of morcellation cut-off of 0.14. The uterine volumes for parous women at predicted probability of morcellation threshold cut-offs of 0.5, 0.7 and 0.9 were 220, 280 and 350 mL, respectively. The sensitivities, specificities, predictive values and LRs for each predicted probability of morcellation are outlined in Table 1 .
DISCUSSION
This study provides a tool for gynecologists to assess preoperatively the need for morcellation using estimated uterine volume, specifically 3D-US uterine volume. It also confirms our previous finding of a superior correlation between 3D-US uterine volume and UDW compared with that of 2D-US and UDW, although in fact we obtained an even weaker correlation of 2D-US to UDW (R = 0.71 compared with R = 0.83, P < 0.001 10 ). 3D-US uterine volume outperformed 2D-US uterine volume both when applied alone and when used in the morcellation logistic regression model 11 . The incorporation of 3D-US volume into the logistic regression model did not seem to confer a significant advantage over using 3D-US volume alone in the prediction of morcellation.
However, along with the use of 3D-US, these preoperative uterine volumes could be incorporated into the previously published morcellation model 11 as an additional tool, providing both individual gynecologists and laparoscopic units with the ability to decide on their own preferred predicted probability of morcellation threshold cut-off to assist in their decision making. Thus, laparoscopic units can adopt a predicted probability of morcellation threshold cut-off depending on the level of risk that they are willing to accept and what is more clinically important to them, i.e. to predict need for morcellation or to avoid morcellation. The LR which is clinically most relevant would determine the predicted probability of morcellation threshold cut-off: if a unit believes that, clinically, the most important outcome is to predict need for morcellation at the time of LH, then they would choose the predicted probability of morcellation threshold cut-off with the highest LR+, i.e. 0.7. Conversely, if they believe it is more important to avoid missing the need for morcellation at the time of LH, then they would choose the predicted probability of morcellation threshold cut-off with the lowest LR-, i.e. 0.14. This preoperative information about the need to morcellate has the potential to improve patient counseling, planning of surgical lists, anticipation of surgical instruments and equipment which may be required and possibly referral to specialized laparoscopic units.
The main limitation of our study is the small size of the cohort of women (especially in the nulliparous group); a larger study would provide for a more accurate and robust assessment of the previously published model. Also, we had fewer women with both 2D-US and 3D-US uterine volumes, although all cases were included and there was no selection bias. However, given the current climate in relation to the use of power morcellation, it would be difficult ethically to approve a larger study. Potentially, there is scope to apply this model to a larger cohort using either cold knife morcellation or 'in-bag' power morcellation at the time of LH. Both approaches could make a larger study more ethically feasible. Another limitation is that the uterine volumes were assessed by one observer. To improve the methodology and generalizability, we could have considered using more than one observer to assess the offline 3D volumetric datasets in order to minimize subjectivity and to allow us to comment on the reproducibility of the technique. Reproducibility studies in the prediction of uterine volume using 3D-US are required to validate this technique.
This study provides a platform to expand routine practice using 3D-US to obtain uterine volumes for women scheduled to undergo a hysterectomy. Given that uterine volumes are not particularly difficult to obtain by 3D-US and given that US, as an imaging modality, has become both readily available and cost-efficient, we suggest that it should be considered as another tool. Larger studies may provide further information with regard to the proportion of women who would be classified as low risk for morcellation and would possibly justify the potential, albeit small, cost of adding 3D-US examination to the preoperative assessment of women scheduled to undergo LH.
In conclusion, the need to morcellate can be predicted preoperatively using uterine volumes obtained by 3D-US with a fair degree of accuracy. The use of 3D-US when incorporated into the previously published logistic regression model does not seem to confer any significant improvement when compared with use of 3D-US alone in predicting the need to morcellate in women undergoing total LH. Further research is required to validate externally the predicted probability of the morcellation model and identify other variables that may be incorporated into the model to improve its performance.
